Molecular therapy for  pulmonary arterial hypertension (PAH): Exemestane (brand name Aromasin), a drug used to treat breast cancer, inhibits the development of pulmonary arterial hypertension via down-regulation of its target gene Notch3, 26/August/2018, 11.03 pm